CureDuchenne Ventures - aVenture Asset Manager Research
Location
Newport Beach, CA, US
Founded
2013
CureDuchenne Ventures is a Newport Beach-based investment firm focused on funding therapies and research projects to treat Duchenne muscular dystrophy. The firm invests across various stages, from seed to post-IPO equity, with a particular emphasis on early-stage investments. Their portfolio spans biotechnology and pharmaceutical companies developing innovative treatments for Duchenne.
Notable portfolio companies include 4D Molecular Therapeutics, Avidity Biosciences, and Entrada Therapeutics. CureDuchenne Ventures' investment philosophy centers on identifying and supporting promising drug targets and programs that have the potential to improve the lives of those affected by Duchenne. The firm leverages its expertise in the field to provide value-add services and strategic guidance to its portfolio companies.
CureDuchenne Ventures - Portfolio Snapshot
Portfolio activity breakdown across disclosed investments and stages